Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents

Front Chem. 2019 Nov 26:7:804. doi: 10.3389/fchem.2019.00804. eCollection 2019.

Authors

H A Arjun¹, Ramakrishnan Elancheran¹, N Manikandan², K Lakshmithendral¹, Muthiah Ramanathan², Atanu Bhattacharjee³, N K Lokanath⁴, Senthamaraikannan Kabilan¹

Affiliations

¹ Drug Discovery Lab, Department of Chemistry, Annamalai University, Chidambaram, India.
² Department of Pharmacology, PSG College of Pharmacy, Coimbatore, India.
³ Computational Biology Laboratory, Department of Biotechnology & Bioinformatics, North Eastern Hill University, Shillong, India.
⁴ Department of Physics, University of Mysore, Mysore, India.

Abstract

[This corrects the article DOI: 10.3389/fchem.2019.00474.].

Keywords: ADME; androgen receptor; benzohydrazide; molecular docking; molecular dynamics; prostate cancer.

Copyright © 2019 Arjun, Elancheran, Manikandan, Lakshmithendral, Ramanathan, Bhattacharjee, Lokanath and Kabilan.

Publication types

Published Erratum
Retracted Publication